This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

Evox’ Exosome Engineering Approach for Surface Display of Biologics Highlighted

Evox’ Exosome Engineering Approach for Surface Display of Biologics Highlighted

07 Oct 2021

LANDMARK PAPER HIGHLIGHTS EVOX THERAPEUTICS’ CUTTING EDGE EXOSOME ENGINEERING APPROACH FOR ENHANCED SURFACE DISPLAY OF BIOLOGICS Evox’s engineered exosomes show better efficacy compared to conventional biologics and significantly outperformed other previously published exosome display platforms Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announces that it has, in close collaboration with one of... Read more

Magdalen College & GIC enter Strategic Partnership to accelerate development of TOSP

Magdalen College & GIC enter Strategic Partnership to accelerate development of TOSP

05 Oct 2021

Magdalen College & GIC enter Strategic Partnership to accelerate development of The Oxford Science Park Investment initiates transformational construction programme as demand for life sciences & technology space continues Oxford, UK, October 5 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, and an affiliate of GIC have entered into a Strategic... Read more

Vatic announces manufacturing partnership with Abingdon Health

Vatic announces manufacturing partnership with Abingdon Health

04 Oct 2021

Abingdon Health plc (“Abingdon Health”), a leading international developer and manufacturer of high quality and effective rapid tests, and Vatic Health Limited (“Vatic”), a UK born health-tech company today announce that they have signed a manufacturing and supply agreement for the Vatic KnowNow™ rapid antigen test, used to detect active SARS CoV-2 in a saliva swab. The innovative science of Vatic’s KnowNow Test combined with one of the... Read more

Exscientia Announces Pricing of $304.7m Upsized IPO & $160m Concurrent Private Placements

Exscientia Announces Pricing of $304.7m Upsized IPO & $160m Concurrent Private Placements

30 Sep 2021

OXFORD, England–(BUSINESS WIRE)– Exscientia plc (Nasdaq: EXAI), an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner, today announced the pricing of its upsized initial public offering in the United States of 13,850,000American Depositary Shares (“ADSs”) representing 13,850,000 ordinary shares at an initial public offering price of $22.00 per ADS,... Read more

Physiomics PARTNER study recruits first patient

Physiomics PARTNER study recruits first patient

21 Sep 2021

Physiomics plc (AIM: PYC), the consultancy using mathematical models to support the development of drug treatment regimens and personalised medicine solutions is pleased to announce its PARTNER study has recruited its first patient.  The study, which received formal Health Research Authority (HRA) ethics approval in December 2020 and started recruiting just this month, has been commissioned to gather data for the further development of... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More